Manufacturer record
Symbiosis Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Symbiosis Pharmaceuticals Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between February 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TG261185, Linezolid Tablets IP 600mg (exp Apr 2028). DTL Baddi (state lab) found it not of standard quality: Dissolution. Listed in the September 2026 alert.
Records by type
11 records linked to Symbiosis Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Linezolid Tablets IP 600mg | Batch TG261185Mfg May 2026 · Exp Apr 2028 | DissolutionDissolution | DTL BaddiState lab | Sep 2026 |
| Linezolid Tablets IP 600mg | Batch TG261185Mfg May 2026 · Exp Apr 2028 | The sample does not conform to claim as per IP 2022 in respect to the Test of Dissolution of Linezolid.Dissolution | DTL-BaddiState lab | Aug 2026 |
| Desogestrel & Ethinyl Estradiol Tablets | Batch SHT-747Mfg Apr 2026 · Exp Mar 2028 | The sample does not conform to declared formula, in respect of Content of Desogestrel & Ethinyl Estradio.Other | LUCKNOW LABState lab | Aug 2026 |
| Cefpodoxime Proxetil Oral Suspension IP | Batch DB25064Mfg Sep 2025 · Exp Aug 2027 | The sample does not conforms to I.P., in respect of content of anhydrous CefpodoximeOther | LUCKNOW LABState lab | Aug 2026 |
| Ondansetron Injection IP | Batch LA24174BMfg Feb 2025 · Exp Jan 2027 | The sample does not comply as per I.P. 2022 with respect to the test for Sterility and BETSterility | RDTL,GuwahatiCDSCO lab | Jan 2026 |
| METHYLCOBALA MIN, FOLIC ACID, ALPHA LIPOIC ACID, VITAMIN B6, CHROMIUM PICOLINATE, SODIUM SELENITE & ZINC SOFT GELATIN CAPSULES (Mi- 6) | Batch SOD- 2470Mfg ? · Exp ? | Does not comply with respect to test for Disintegration -NSQDisintegration | PuducherryState lab | Feb 2025 |
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP (Levmont) | Batch ST23- 384DMfg May 2023 · Exp Apr 2025 | Dissolution of Montelukast Levocetirizine hydrochlorideDissolution | RDTL GuwahatiCDSCO lab | Jun 2024 |
| Doxycycline and Lactic Acid Bacillus Capsules(DOXORIA-L) | Batch SOC- 2062AMfg Nov 2022 · Exp Oct 2024 | Assay /Content of Gram positive rod shaped spore forming bacteriaAssay | CDL KolkataCDSCO lab | Aug 2023 |
| Methylcobalamin, Alpha Lipoic Acid, Pyridoxine HCI and Folic Acid Capsules (VEMIFOL PLUS CAPSULES) | Batch SOC-1911AMfg Feb 2022 · Exp Jan 2024 | Assay of Alpha Lipoic AcidAssay | RDTL ChandigarhCDSCO lab | May 2022 |
| DOXYGUARD (Doxycycline & Lactic Acid Bacillus Capsules) | Batch SOC-615FMfg Jan 2018 · Exp Dec 2019 | Assay/Content of Lactic Acid BacillusAssay | CDL KolkataCDSCO lab | Nov 2019 |
| Doxycycline and Lactic Acid Bacillus Capsules (DOXYGUARD CAPSULES) | Batch SOC-615FMfg Jan 2018 · Exp Dec 2019 | Assay of Lactic Acid BacillusAssay | RDTL ChandigarhCDSCO lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.